Clinical Trials Browser

Phase 2 × Docosahexaenoic Acids × Breast × Clear all

NCT03831178 2025-06-26

DHA-WIN

Phase 2 Active not recruiting

Breast Neoplasms

NCT01849250 2021-12-28

Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors

Phase 2 Completed

65 enrolled 11 charts

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Paget's Disease, Mammary